LIGHTMIX ZIKA RRT-PCR TEST (EUA) 07987897001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-03-09 for LIGHTMIX ZIKA RRT-PCR TEST (EUA) 07987897001 manufactured by Olfert Landt, Tib Molbiol Syntheselabor Gmbh.

Event Text Entries

[69867215] The investigation into the generation of the false positive results and drifting baselines is currently on-going. A supplemental report will be provided at the end of the investigation. Roche molecular systems holds the eua for this product. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[69867216] The customer in the united states is observing a baseline drift in the target pcr curve, which is raising the fluorescence intensity ratio (fir) for presumed, negative samples (serum) to be close to or above the 10 percent cut-off value indicated in the lightmix zika rrt-pcr test, eua instructions for use. Per the instructions for use, when the fir is >/= 10 percent, the result for the zika assay is considered valid and the interpretation of the specimen is positive for zika virus. The customer is running serum, plasma, and urine samples; the baseline drift is most significant with the serum samples. The customer site is currently validating and not yet testing clinical samples, so no results have been reported. There is no indication of harm or injury, to date, as a result of the alleged false positive zika results.
Patient Sequence No: 1, Text Type: D, B5


[75537834] The customer in the united states alleged the generation of false positive when testing presumed negative samples with the lightmix zika rrt-pcr test, eua, following the instructions for use and the fluorescence intensity ratio (fir). Per the instructions for use, when the fir is >/= 10 percent, the result for the zika assay is considered valid and the interpretation of the specimen is positive for zika virus. The customer confirmed that they were not testing clinical samples, so no false results were reported. As this customer and another (reported in a separate medical device report: 2243471-2017-00005) were generating false positive results with the implementation of the fir, roche informed customers to discontinue use and discard any remaining inventory of the lightmix zika rrt-pcr test, eua. Additionally, roche requested to the u. S. Food and drug administration (fda) to withdraw this test. On 13-mar-2017, roche received the fda's notice of revocation. A capa was initiated to identify the root cause for the false positive results and drifting baseline. Corrective and preventive measures will be implemented as appropriate. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2017-00004
MDR Report Key6391756
Date Received2017-03-09
Date of Report2017-05-08
Date of Event2017-01-23
Date Mfgr Received2017-02-08
Date Added to Maude2017-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA TIMOTHY BLAIR
Manufacturer Street1080 US HWY 202 S NA
Manufacturer CityBRANCHBURG NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone9082537918
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameLIGHTMIX ZIKA RRT-PCR TEST (EUA)
Generic NameREAGENTS, ZIKA VIRUS NUCLEIC ACID
Product CodePOA
Date Received2017-03-09
Model NumberNA
Catalog Number07987897001
Lot Number38161612
ID NumberNA
Device Expiration Date2017-09-30
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOLFERT LANDT, TIB MOLBIOL SYNTHESELABOR GMBH
Manufacturer AddressERESBURGSTR. 22-23 NA BERLIN 12103 12103


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.